Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia
In ETV-treated patients with LLV, receiving NAs plus pegIFN-α tends to increase the effect of HBsAg clearance.
Authors
- Xinyue Chen (ORCID: https://orcid.org/0000-0001-9569-4540)
- Junfeng Lu (ORCID: https://orcid.org/0000-0001-6458-7734)
- Sujun Zheng
- Zhongjie Hu (ORCID: https://orcid.org/0000-0001-7313-5326)
- Shan Ren (ORCID: https://orcid.org/0000-0002-5279-6464)
- L Q Wang (ORCID: https://orcid.org/0009-0006-3357-2349)
- Dan Liu (ORCID: https://orcid.org/0009-0004-5649-3948)
Institutions
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3389/fmed.2025.1642961
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Beijing Municipal Health Commission
- National Key Research and Development Program of China